Navigation Links
UNC study hints at new approaches to prevent transplant rejection
Date:2/11/2009

CHAPEL HILL To prevent the rejection of newly transplanted organs and cells, patients must take medicines that weaken their entire immune systems. Such potentially life-saving treatments can, paradoxically, leave those receiving them susceptible to life-threatening infections.

Now researchers at the University of North Carolina at Chapel Hill School of Medicine and the UNC Lineberger Comprehensive Cancer Center have discovered what seems to trigger the immune system to attack transplanted cells in the first place.

The finding could help chart a course to completely new therapies that may prevent graft-versus-host disease the main cause of transplant failure and its sometimes fatal complications.

The UNC study has identified a subset of cells named TH17 cells that can bring about the condition. Until now, without a clear understanding of the disease, clinicians have had little choice but to treat transplant patients with toxic regimens of steroids and immunosuppressive drugs.

"Our hope is that uncovering the mechanisms that cause graft-versus-host disease will allow for treatments that specifically target its causes and do not have the harmful side effects of traditional immunosuppressive therapy," said study lead author Jonathan S. Serody, M.D., a member of the Lineberger Center and the Elizabeth Thomas Professor of Medicine, Microbiology and Immunology at UNC. The results of the study appeared in the Feb. 5, 2009, issue of Blood, the journal of the American Society of Hematology.

Graft-versus-host disease (GVHD) is a serious complication of transplants that occurs when the donor's marrow (graft) produces immune cells that attack multiple organs of the recipient (host), typically the skin, gastrointestinal tract and liver.

Until recently, scientists believed that most of the disease's problems came from the production of specific molecules called interferons, a class of proteins that arise in
'/>"/>

Contact: Dianne Shaw
dgs@med.unc.edu
919-966-7834
University of North Carolina School of Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Higher blood sugar levels linked to lower brain function in diabetics, study shows
2. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study
3. Published Study Shows Brain Exercises Improve Memory and Attention - And People Notice
4. Study: Genetic Risk for Substance Use Can be Neutralized by Good Parenting
5. Study finds race and ethnicity affect use of hospice services among patients with advanced cancer
6. Study: Genetic risk for substance use can be neutralized by good parenting
7. New Study Reveals Shake-Up in the Most Promising AEC Markets for 2009
8. Study Finds Lifeclinic Self-Testing Health Stations in Workplace Help Reduce Hypertension and Obesity
9. Most seniors have drug coverage, study shows
10. NADP Study Reports Dramatic Increase in Value of Dental Benefits
11. First brain study reveals benefits of exercise on quitting smoking
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Vegas, NV (PRWEB) July 31, 2014 ... to helping independent pharmacies enhance patient care by ... compliance and medication adherence. The first of many ... the opening of ThoughtSpot 2014, Good Neighbor Pharmacy ... for Medicare and Medicaid Services (CMS) Star Measures ...
(Date:7/31/2014)... 2014 The controversy surrounding uterine ... notes that Johnson & Johnson’s Ethicon, Inc. unit ... its power morcellators ( http://www.gynecaremorcellatorlawsuit.com/ ) from the ... company said it decided to do so because ... remain uncertain.* , “In light of mounting evidence ...
(Date:7/31/2014)... 31, 2014 Model moms are believers. PBS ... reports positions in the field have grown exponentially in the ... any thriving industry, there are associated myths that need to ... is Frontier Nursing University . Celebrating 75 years in ... program in the nation. “Frontier is changing the face ...
(Date:7/31/2014)... Clifton Dental Associates is now proud ... fluoride treatments to their adult patients to aid in ... sensitivity in patients that exhibit symptoms. Dental caries, ... commonly known as “tooth decay” or a “cavity.” This ... , Fluoride therapy is the delivery of ...
(Date:7/31/2014)... The July 2014 issue of ... an open access journal featuring the following articles:, ... generating multicomponent , Graphene veils: A ... A workflow to increase verification rate of chromosomal ... Quantification of particle-conjugated or particle-encapsulated peptides on ...
Breaking Medicine News(10 mins):Health News:Good Neighbor Pharmacy Reinforces Commitment to Helping Enhance Patient Care 2Health News:Good Neighbor Pharmacy Reinforces Commitment to Helping Enhance Patient Care 3Health News:Uterine Morcellation Controversy Grows, as Bernstein Liebhard LLP Notes Johnson & Johnson Decision to Withdraw Power Morcellators from Market 2Health News:Uterine Morcellation Controversy Grows, as Bernstein Liebhard LLP Notes Johnson & Johnson Decision to Withdraw Power Morcellators from Market 3Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 2Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 3Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 4Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 5Health News:NJ Top Dentists Approved, Clifton Dental Associates Now Actively Recommending the Application of Topical Fluoride Treatments to Adults 2Health News:BioTechniques: The International Journal of Life Science Methods Announces the Publication of the July 2014 Issue—Available in Print and Online as an Open Access Journal 2Health News:BioTechniques: The International Journal of Life Science Methods Announces the Publication of the July 2014 Issue—Available in Print and Online as an Open Access Journal 3
... Dr. Khanna wants to thank ... in a row. , ... 2010 -- Repeat is sure sweet. Dr. Khanna and The Khanna Institute of Lasik & ... LASIK surgeon by the readers of the Ventura County Star. This achievement is notably recognized and ...
... tie-in to tremors and other motor problems , ... how a mutation in a gene called LRRK2 may ... , In experiments using genetically engineered mice, the Mount ... dopamine transmission and controls motor performance. Dopamine is a ...
... Calif.Scientists from the California Institute of Technology (Caltech) have ... key proteingp120found on the surface of a specific subgroup ... demonstrated that a particular antibody to gp120 makes contact ... receptor that gp120 uses to gain entrance into the ...
... Treatment Service has been named a "Clinical Center of Excellence" ... upon five pain centers each year. This is the first ... are honored to be named a Clinical Center of Excellence ... chief of the pain management department at Children,s. "Everyone in ...
... too , FRIDAY, April 2 (HealthDay News) -- Death can ... own death, or that of a loved one. , Yet ... information from such talks, people can make sure that their ... followed when it,s most crucial. , "It,s very important to ...
... , ... According to a survey conducted by the Greater New England ... that they were supportive of the recently passed health care reform legislation. ... themselves and their employees. The survey also found that 61 percent ...
Cached Medicine News:Health News:Dr. Rajesh Khanna Selected as Best Lasik Surgeon Two Years in a Row 2Health News:Caltech scientists uncover structure of key protein in common HIV subgroup 2Health News:Caltech scientists uncover structure of key protein in common HIV subgroup 3Health News:Start Talking About Life's End Well in Advance 2Health News:Start Talking About Life's End Well in Advance 3Health News:Minority Businesses Support Health Care Reform Legislation, According to Survey 2
(Date:7/31/2014)... 2014 Orexigen® Therapeutics, Inc. (Nasdaq: ... quarter 2014, on Thursday, August 7, 2014 before markets ... webcast and conference call at 8:00 a.m. Eastern time ... host the call and webcast to discuss financial results ... accessed by calling (800) 708-4540 (domestic) or (847) 619-6397 ...
(Date:7/31/2014)... -- Nutrastar International Inc. (OTCQB: NUIN; "Nutrastar" or the ... consumer products, including commercially cultivated Cordyceps Militaris ("Cordyceps"), health ... signing of its first distributor for its new Cordyceps ... Hubei Province located in the ... The contract with the new distributor, ...
(Date:7/31/2014)... -- Northsight Capital, Inc. (OTCBB: NCAP) announced today that businessman ... of the company. Mr. Bluher has extensive experience in ... investment banking. Mr. Bluher has over 15 years of ... Wall Street, Mr. Bluher was also Senior Counsel in ... Commission in Washington D.C.   ...
Breaking Medicine Technology:Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast 2Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 2Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 3Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 4Northsight Capital, Inc. Names Wall Street Veteran John Bluher, Former EVP And General Counsel Of Knight Trading Group, Chairman And CEO. 2
... April 20, 2012  In a time of rapid ... rethinking their use of technology, applications and workflow. ... for health and human services organizations nationwide, today ... help providers deliver accountable, recovery-based care in the ...
... April 20, 2012 There are some two dozen oncology ... earlier stages of development. While only some of these therapies ... yet another hurdle: a competitive marketplace where success revolves around ... environment, pharmaceutical organizations in the oncology therapeutic area must constantly ...
Cached Medicine Technology:Netsmart's Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment 2Netsmart's Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment 3Netsmart's Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment 4Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector 2
Bio-Rad's Genetic Systems™ HBsAg EIA 3.0 screening and confirmatory assays offer outstanding sensitivity and early detection of HBV infection, helping to meet your testing criteria....
... Cryo System is the first in portability and performance. ... surgeons who need a flexible, portable system with the ... CTU attaches easily to an "E" size tank and ... cryo to where it is needed.,The CTU Travel Case ...
The most compact revolutionary innovation in hematology. 3 Part DIFF + CRP measurement on whole blood....
The most compact revolutionary innovation in hematology. 26 parameters with 5 Part DIFF...
Medicine Products: